Smartphone Message to Improve the Drug Compliance in Pregnant Women.
NCT ID: NCT04295265
Last Updated: 2020-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
228 participants
INTERVENTIONAL
2020-03-01
2024-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that the use of smartphone message will improve the drug compliance in pregnant women requiring long term medications. The investigators propose a randomized controlled trial to evaluate the effect of smartphone message.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Mobile Phone Based Medication Reminder Program
NCT02793830
Improving Medication Adherence: A Study With Talking Pill Bottles
NCT02827773
Improving Medication Adherence Through SMS (Short Messaging Service) in Adult Stroke Patients: a Randomised Controlled Behaviour Intervention Trial
NCT01986023
SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs
NCT04052750
Text Messages for Liver Transplant Recipients
NCT04995770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smartphone
Receive daily whatsapp/ SMS message remind the drug intake.
smartphone message
Receive daily whatsapp/ SMS message to remind the drug intake
Control
receive instruction to take the medication at recruitment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smartphone message
Receive daily whatsapp/ SMS message to remind the drug intake
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to receive electronic reminder through smartphohne
* Gestational age less than 16 completed weeks as defined by pelvic ultrasound
* Part 1: Need to take aspirin or progesterone for prevention of pre-eclampsia or preterm birth respectively
* Part 2: Given multivitamin as health supplementation
Exclusion Criteria
* History of adverse reaction to aspirin
* History of adverse reaction to progesterone
* History of breast or genital tract malignancy
* History of suspected thromboembolic disease
* Congenital uterine anomaly
* Unwillingness or inability to comply with study procedures
* Known paternal or maternal abnormal karyotype
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UW 19-552
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.